000 | 01921 a2200553 4500 | ||
---|---|---|---|
005 | 20250518005647.0 | ||
264 | 0 | _c20190920 | |
008 | 201909s 0 0 eng d | ||
022 | _a2213-6711 | ||
024 | 7 |
_a10.1016/j.stemcr.2018.10.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLemme, Marta | |
245 | 0 | 0 |
_aAtrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium. _h[electronic resource] |
260 |
_bStem cell reports _c12 2018 |
||
300 |
_a1378-1390 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a4-Aminopyridine _xpharmacology |
650 | 0 | 4 |
_aAction Potentials _xdrug effects |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Size _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aHeart Atria _xanatomy & histology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aModels, Cardiovascular |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aOrgan Specificity _xdrug effects |
650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aPotassium Channels _xmetabolism |
650 | 0 | 4 |
_aReceptors, Muscarinic _xmetabolism |
650 | 0 | 4 |
_aTissue Engineering _xmethods |
650 | 0 | 4 |
_aTretinoin _xpharmacology |
700 | 1 | _aUlmer, Bärbel M | |
700 | 1 | _aLemoine, Marc D | |
700 | 1 | _aZech, Antonia T L | |
700 | 1 | _aFlenner, Frederik | |
700 | 1 | _aRavens, Ursula | |
700 | 1 | _aReichenspurner, Hermann | |
700 | 1 | _aRol-Garcia, Miriam | |
700 | 1 | _aSmith, Godfrey | |
700 | 1 | _aHansen, Arne | |
700 | 1 | _aChrist, Torsten | |
700 | 1 | _aEschenhagen, Thomas | |
773 | 0 |
_tStem cell reports _gvol. 11 _gno. 6 _gp. 1378-1390 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.stemcr.2018.10.008 _zAvailable from publisher's website |
999 |
_c29031793 _d29031793 |